Explore Biotech Companies

Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision small molecule medicines for neurological disorders with neuroanatomical specificity.

📍 Boston, MA

Radius Health is a biopharmaceutical company focused on bone health and related conditions, utilizing small molecules and biologics.

📍 Boston, MA

Qynapse is a biotech company specializing in AI-powered neuroimaging analysis for CNS disorders, improving screening and monitoring accuracy.

📍 Boston, MA

Pyxis Oncology is a clinical-stage biotech company developing antibody immunotherapy and next-generation therapeutics to target difficult-to-treat cancers.

📍 Boston, MA

PureTech Health is a biotherapeutics company focused on developing therapies for devastating diseases, particularly in the areas of the brain, immune system, and gut axis.

📍 Boston, MA

PsiThera (formerly Psivant Therapeutics) uses physics-driven AI for drug design, creating oral small molecules for challenging disease targets.

📍 Boston, MA

Protein Metrics provides vendor-neutral mass spectrometry software for biotherapeutic protein characterization and analysis.

📍 Boston, MA

Prologue Medicines leverages viral-derived biologics and proteins, using their DELVE™ Platform and evolutionary insights to create transformative programmable medicines.

📍 Boston, MA

Precede Biosciences is a biotech company with a liquid biopsy platform revolutionizing precision medicine by revealing disease-defining biology from a blood test.

📍 Boston, MA

Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing genetic neuroscience treatments for CNS disorders like epilepsy, focusing on neuronal excitation-inhibition imbalance.

📍 Boston, MA

PostEra is a biotech company using AI and machine learning for medicinal chemistry and preclinical drug discovery, aiming to accelerate the development of new medicines.

📍 Boston, MA

PhAST Diagnostics uses AI imaging technology for rapid infectious disease diagnostics and antimicrobial susceptibility testing, harnessing single-cell imaging and a cloud-based platform.

📍 Boston, MA

Pepper Bio is a trans-omics drug discovery company using phosphoproteomic data and AI to create treatments for previously untreatable diseases.

📍 Boston, MA

PepGen uses peptide conjugation technology and Enhanced Delivery Oligonucleotides (EDOs) to develop oligonucleotide therapies for neuromuscular and neurological diseases.

📍 Boston, MA

PathMaker Neurosystems is a clinical-stage neuromodulation company developing non-invasive devices for ALS and other neurodegenerative disorders.

📍 Boston, MA

AI-powered pathology company transforming patient outcomes and drug development with advanced diagnostic solutions.

📍 Boston, MA

Paratek Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing small molecule antibiotics to combat AMR and other life-threatening infectious diseases.

📍 King of Prussia, PA

Ovid Therapeutics is a biopharmaceutical company developing targeted small molecule therapies for rare brain disorders, including epilepsies and conditions like Fragile X Syndrome.

📍 New York, NY

Global gene therapy leader developing ex vivo autologous hematopoietic stem cell gene therapies for severe genetic and rare diseases.

📍 Boston, MA

Opus Regulatory is a niche regulatory affairs consulting firm serving biopharmaceutical companies nationwide, founded in 1994.

📍 Boston, MA

Omixon provides next-gen sequencing products for HLA genotyping and transplantation diagnostics, empowering clinical labs with innovative molecular diagnostic technologies.

📍 Boston, MA

Odyssey Therapeutics develops precision immunomodulators for autoimmune and inflammatory diseases, utilizing small molecule and biologic drug discovery.

📍 Ann Arbor, MI

Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company using computational technology to design small molecule medicines.

📍 Boston, MA

Nido Biosciences developed small molecule therapies for neurodegenerative diseases but is closing operations in early 2026 after a Phase 2 trial failed.

📍 Boston, MA